UPDATED Apr 03, 2024
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
PHAR | €10.96 | 1.1% | -7.2% | €677.8m | €21.70 | PS3x | E52.8% | n/a | ||
EXAS | US$72.82 | 8.9% | 13.0% | US$13.2b | US$88.49 | PS5.3x | E61.5% | n/a | ||
PHGU.F | €1.20 | 0% | 1.7% | €677.8m | €2.38 | PS3x | E52.8% | n/a | ||
BGNE | US$151.95 | -2.0% | -28.3% | US$15.9b | US$269.36 | PS6.5x | E56.6% | n/a | ||
AMRN | US$1.06 | 19.2% | -22.6% | US$435.3m | US$1.08 | PS1.4x | E51.2% | n/a | ||
AUPH | US$5.18 | 3.6% | -48.1% | US$749.1m | US$10.57 | PS4.3x | E53.7% | n/a |